Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
- PMID: 38060004
- PMCID: PMC11213772
- DOI: 10.1007/s00330-023-10411-x
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee
Abstract
The Contrast Media Safety Committee of the European Society of Urogenital Radiology has, together with the Preanalytical Phase Working Group of the EFLM Science Committee, reviewed the literature and updated its recommendations to increase awareness and provide insight into these interferences. CLINICAL RELEVANCE STATEMENT: Contrast Media may interfere with clinical laboratory tests. Awareness of potential interference may prevent unwanted misdiagnosis. KEY POINTS: • Contrast Media may interfere with clinical laboratory tests; therefore awareness of potential interference may prevent unwanted misdiagnosis. • Clinical Laboratory tests should be performed prior to radiological imaging with contrast media or alternatively, blood or urine collection should be delayed, depending on kidney function.
Keywords: Analytical chemistry; Clinical laboratory techniques; Clinical practice guideline; Contrast agents; Diagnostic error.
© 2023. The Author(s).
Conflict of interest statement
The authors of this manuscript declare relationships with the following companies:
Aart J. van der Molen: Guerbet
Ilona A. Dekkers: Guerbet
Remy W.F. Geenen: none
Marie-France Bellin: is a member of the European Radiology Advisory Editorial Board but has not taken part in the review or selection process of this article.
Michele Bertolotto: none
Torkel B Brismar: is a member of the European Radiology Scientific Editorial Board but has not taken part in the review or selection process of this article.
Jean-Michel Correas: Bracco Imaging, Guerbet
Gertraud Heinz-Peer: none
Andreas H. Mahnken: none
Carlo C. Quattrocchi: Bracco Imaging, Guerbet, Bayer Healthcare, GE Healthcare
Alexander Radbruch: none
Peter Reimer: none
Giles Roditi: none
Laura Romanini: none
Carmen Sebastià: none
Fulvio Stacul: none
Olivier Clement: Bracco Imaging, Guerbet, Bayer Healthcare
The contrast media companies Bayer Healthcare, Bracco Imaging, GE Healthcare, and Guerbet are consultants to the ESUR Contrast Media Safety Committee and participate in all scientific discussions but are not involved in any of the final recommendations.
Similar articles
-
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee.Clin Chem Lab Med. 2023 Dec 6;62(4):608-614. doi: 10.1515/cclm-2023-1184. Print 2024 Mar 25. Clin Chem Lab Med. 2023. PMID: 38050439
-
[Joint EFLM-COLABIOCLI recommendation for venous blood sampling].Ann Biol Clin (Paris). 2019 Apr 1;77(2):131-154. doi: 10.1684/abc.2019.1419. Ann Biol Clin (Paris). 2019. PMID: 30998194 Review. French.
-
Recommendations for blood sampling in emergency departments from the European Society for Emergency Medicine (EUSEM), European Society for Emergency Nursing (EuSEN), and European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase. Executive summary.Clin Chem Lab Med. 2024 Apr 8;62(8):1538-1547. doi: 10.1515/cclm-2024-0059. Print 2024 Jul 26. Clin Chem Lab Med. 2024. PMID: 38581294
-
Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE).Clin Chem Lab Med. 2017 Mar 1;55(4):489-500. doi: 10.1515/cclm-2017-0107. Clin Chem Lab Med. 2017. PMID: 28231060
-
The EFLM strategy for harmonization of the preanalytical phase.Clin Chem Lab Med. 2018 Sep 25;56(10):1660-1666. doi: 10.1515/cclm-2017-0277. Clin Chem Lab Med. 2018. PMID: 28593910 Review. No abstract available.
Cited by
-
Incidence, outcome, and risk factors of contrast media extravasation injury during contrast-enhanced computed tomography scans: an observational cohort study.Quant Imaging Med Surg. 2025 Aug 1;15(8):7338-7351. doi: 10.21037/qims-24-2332. Epub 2025 Jul 25. Quant Imaging Med Surg. 2025. PMID: 40785883 Free PMC article.
References
-
- Morcos SK, Thomsen HS, Exley CM; Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) Contrast media: interactions with other drugs and clinical tests. Eur Radiol 15:1463-1468 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources